P&T [Pharmacy and Therapeutics]

P&T [Pharmacy and Therapeutics] A peer-reviewed journal for managed care and hospital formulary management.

P&T provides pharmacy and therapeutics committee members with the latest information to help them manage their formularies and establish medication-related policies. Articles are authored by experts in the field and undergo a thorough peer review. P&T includes cost-containment and error-prevention strategies, drug utilization evaluations, and disease management information.

Mission: P&T® provides managed care and formulary management decision-makers with the latest information to help them manage their formularies and establish medication-­related policies.

Looking for Trouble: Identifying and Treating Hypotension
09/21/2019
Looking for Trouble: Identifying and Treating Hypotension

Looking for Trouble: Identifying and Treating Hypotension

When it comes to blood pressure (BP), hypertension gets most of the attention. This is not surprising, as an estimated 46% of Americans have the condition1 and it can have deadly consequences. In 2013 alone, high BP was a primary or contributing cause in almost 1,000 deaths a day.2

Bipartisan Drug-Patent Bills Ready for Senate Vote
09/20/2019
Bipartisan Drug-Patent Bills Ready for Senate Vote

Bipartisan Drug-Patent Bills Ready for Senate Vote

The legal tactics that drug manufacturers use to extend drug patents may be the big-gest impediment to lowering drug prices and to Congress acting on pricing. Until now, that is.

“It Starts With One”: Reflections on BIO 2019
08/07/2019
“It Starts With One”: Reflections on BIO 2019

“It Starts With One”: Reflections on BIO 2019

This year’s Biotechnology Innovation Organization (BIO) meeting, held in Philadelphia from June 3 to June 6, had an impressive turnout of 17,307 attendees and 1,800 exhibitors. We review two sessions on the outlook for value-based payment for transformative therapies and what’s in store for futu...

American Society of Clinical Oncology 2019
08/07/2019
American Society of Clinical Oncology 2019

American Society of Clinical Oncology 2019

The 2019 ASCO annual meeting held in Chicago, Illinois, from May 31 to June 4, hosted tens of thousands of oncology professionals. We review key sessions on prostate cancer, urothelial cancer, non–small-cell lung cancer, gastric and gastroesophageal cancers, smoldering multiple myeloma, breast can...

Research Briefs August 2019
08/07/2019
Research Briefs August 2019

Research Briefs August 2019

In 2017, the number of cases of tick-borne spotted fever rickettsiosis (SFR) reported to the Centers for Disease Control and Prevention (CDC) jumped 46%—from 4,269 in 2016 to a record 6,248 cases. In 2017 alone, the New England, East North Central, and Mid-Atlantic regions experienced an increase ...

Employer-Provider Interface Council (EPIC) 2019: Managing Health Benefits In The Era Of Change
08/07/2019
Employer-Provider Interface Council (EPIC) 2019: Managing Health Benefits In The Era Of Change

Employer-Provider Interface Council (EPIC) 2019: Managing Health Benefits In The Era Of Change

The inaugural meeting of EPIC (Employer-Provider Interface Council) took place on June 11, 2019, at Rutgers University’s Ernest Mario School of Pharmacy in Piscataway, New Jersey, with the theme of “Managing Health Benefits in the Era of Change.” The conference, which featured a roundtable dis...

Outcomes of Inpatient Administration of Restricted Antineoplastic Medications at a Large Academic Medical Institution
08/06/2019
Outcomes of Inpatient Administration of Restricted Antineoplastic Medications at a Large Academic Medical Institution

Outcomes of Inpatient Administration of Restricted Antineoplastic Medications at a Large Academic Medical Institution

Administering oncology medications has shifted from the inpatient to the outpatient setting because of new, minimal-toxicity regimens, rising drug costs, and a movement toward value-based care. As payer reimbursements decrease, healthcare organizations must find ways to reduce costs while maintainin...

Savings on High-Cost Drugs Such as Atypical Long-Acting Injectable Antipsychotics: Switching to Billing Under the Pharma...
08/06/2019
Savings on High-Cost Drugs Such as Atypical Long-Acting Injectable Antipsychotics: Switching to Billing Under the Pharmacy Benefit in Outpatient Settings

Savings on High-Cost Drugs Such as Atypical Long-Acting Injectable Antipsychotics: Switching to Billing Under the Pharmacy Benefit in Outpatient Settings

In the case of atypical, long-acting injectable (LAI) antipsychotics, billing under the medical benefit option can cause a significant financial loss. By switching to billing under the pharmacy benefit option, savings can be made in some cases when the use of LAIs and other costly medications is req...

From Then Until Now: A Top-Down View Of The Affordable Care Act
08/06/2019
From Then Until Now: A Top-Down View Of The Affordable Care Act

From Then Until Now: A Top-Down View Of The Affordable Care Act

How does the Patient Protection and Affordable Care Act (ACA) of 2010 differ from the act as it stands today? Many changes have occurred, in Medicaid expansion, private insurance coverage, the American Health Benefit Exchanges, and the individual mandate.

Chloral Hydrate: Is It Still Being Used? Are There Safer Alternatives?
08/05/2019
Chloral Hydrate: Is It Still Being Used? Are There Safer Alternatives?

Chloral Hydrate: Is It Still Being Used? Are There Safer Alternatives?

Using chloral hydrate carries a risk of adverse events and compounding errors, and much of the available literature recommends using alternative sedatives for pediatric patients. But evidence regarding the efficacy of chloral hydrate and of alternative agents is conflicting.

Politics, Healthcare Costs, and Access: A Toxic Brew?
07/06/2019
Politics, Healthcare Costs, and Access: A Toxic Brew?

Politics, Healthcare Costs, and Access: A Toxic Brew?

In the latest interview with P&T, Dr. David Nash discusses the prospects for bipartisan legislation on reigning in prescription costs; eliminating drug shortages; and opaque hospital charges, along with the latest report from the Pharmacy Quality Alliance on access to care. He also discusses the nee...

Will the Bili-ruler Rule?
05/24/2019
Will the Bili-ruler Rule?

Will the Bili-ruler Rule?

Novel, Low-cost Device Highly Accurate at Screening Newborn Jaundice

Address

780 Township Line Rd
Yardley, PA
19067

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

(267) 685-3422

Alerts

Be the first to know and let us send you an email when P&T [Pharmacy and Therapeutics] posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to P&T [Pharmacy and Therapeutics]:

Nearby media companies


Other Yardley media companies

Show All